Share

May 28, 2013; 80 (22) Article

Exposure to pesticides or solvents and risk of Parkinson disease

Gianni Pezzoli, Emanuele Cereda
First published May 27, 2013, DOI: https://doi.org/10.1212/WNL.0b013e318294b3c8
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1429

Share

Article Information

vol. 80 no. 22 2035-2041
DOI: 
https://doi.org/10.1212/WNL.0b013e318294b3c8
PubMed: 
23713084
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received September 18, 2012
  • Accepted in final form February 14, 2013
  • First Published May 27, 2013.
Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Gianni Pezzoli, MD and
    2. Emanuele Cereda, MD, PhD
  1. Gianni Pezzoli, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Emanuele Cereda, MD, PhD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Speaker honoraria from Nutricia Italia and Nestlè

    Editorial Boards:

    1. Editorial board membership of the following journals: (1) The Open Geriatric Medicine Journal (2) The Open Heart Failure Journal (3) The World Journal of Meta-Analyses

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Nutricia Italia

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Investigator grants from Nutricia Italia

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Investigator grants from (1) the “Fondazione Grigioni per il Morbo di Parkinson” and (2) the Fondazione IRCCS Policlinico San Matteo

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Parkinson Institute (G.P.), Istituti Clinici di Perfezionamento, Milan; and Fondazione IRCCS Policlinico San Matteo (E.C.), Pavia, Italy.
  1. Correspondence to Dr. Cereda: e.cereda{at}smatteo.pv.it
View Full Text

Article usage

Article usage: May 2013 to April 2022

AbstractFullPdfSource
May 201326555093Highwire
Jun 201321152365713Highwire
Jul 20137071824Highwire
Aug 20134971223Highwire
Sep 20135651919Highwire
Oct 20136492013Highwire
Nov 20135692828Highwire
Dec 201330447Highwire
Jan 20144091020Highwire
Feb 20143701011Highwire
Mar 2014370513Highwire
Apr 201433878Highwire
May 201428452Highwire
Jun 201422135Highwire
Jul 201421744Highwire
Aug 201421832Highwire
Sep 201423733Highwire
Oct 201429949Highwire
Nov 201427226Highwire
Dec 201420569Highwire
Jan 201522500Highwire
Feb 201523774Highwire
Mar 2015324712Highwire
Apr 2015243410Highwire
May 201527935Highwire
Jun 201523144Highwire
Jul 201524016Highwire
Aug 201521515Highwire
Sep 201524175Highwire
Oct 201517075Highwire
Nov 201516416Highwire
Dec 201517544Highwire
Jan 201617323Highwire
Feb 201615944Highwire
Mar 201618563Highwire
Apr 201615754Highwire
May 201619732Highwire
Jun 201626602Highwire
Jul 201615221Highwire
Aug 201617224Highwire
Sep 201615600Highwire
Oct 201617554Highwire
Nov 201614545Highwire
Dec 201657114Highwire
Jan 201731502Highwire
Feb 201712673Highwire
Mar 201719012Highwire
Apr 201718824Highwire
May 201717247Highwire
Jun 201710412Highwire
Jul 201714322Highwire
Aug 201710022Highwire
Sep 201713002Highwire
Oct 201714722Highwire
Nov 20179711Highwire
Dec 201710931Highwire
Jan 201818030Highwire
Feb 2018140111Highwire
Mar 2018158124Highwire
Apr 201818484Highwire
May 2018250259Highwire
Jun 201829184Highwire
Jul 201827966Highwire
Aug 201824159Highwire
Sep 201823843Highwire
Oct 2018312511Highwire
Nov 2018233515Highwire
Dec 201818276Highwire
Jan 201924668Highwire
Feb 201933687Highwire
Mar 201921716Highwire
Apr 2019215816Highwire
May 201915655Highwire
Jun 201916357Highwire
Jul 2019162816Highwire
Aug 2019391710Highwire
Sep 201918736Highwire
Oct 201922546Highwire
Nov 2019182712Highwire
Dec 201916731Highwire
Jan 202014123Highwire
Feb 202019823Highwire
Mar 2020159157Highwire
Apr 202015422Highwire
May 202017395Highwire
Jun 202029714Highwire
Jul 202017122Highwire
Aug 202015449Highwire
Sep 202024922Highwire
Oct 202020044Highwire
Nov 202015557Highwire
Dec 2020124179Highwire
Jan 202118613Highwire
Feb 202119123Highwire
Mar 202123131Highwire
Apr 202128774Highwire
May 202121922Highwire
Jun 202124614Highwire
Jul 202122048Highwire
Aug 202124344Highwire
Sep 202125955Highwire
Oct 202125265Highwire
Nov 202123342Highwire
Dec 202120442Highwire
Jan 202219797Highwire
Feb 202222922Highwire
Mar 202230153Highwire
Apr 202224811Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

  • Solvents and Parkinson's disease
    • Jean-Marc Raymackers, Clinique Saint-Pierre, Ottignies (Belgium)
    Submitted June 24, 2013
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me